Oral Cancer Rapid Test Kit Market Introduction and Overview
According to SPER Market Research, the Global Oral Cancer Rapid Test Kit Market is estimated to reach USD 3.70 billion by 2033 with a CAGR of 5.42%.
The report includes an in-depth analysis of the Global Oral Cancer Rapid Test Kit Market, including market size and trends, product mix, applications, and supplier analysis. An oral cancer quick test kit is a diagnostic tool meant to detect mouth cancer in its earliest stages by identifying biomarkers linked with the disease. Oral cancer, a subtype of head and neck cancers, mostly impacts the lips, tongue, cheeks, floor of the mouth, and hard palate. Early identification of oral cancer is critical since it greatly improves the probability of successful treatment and survival. The primary objective of rapid test kits is to provide a simple, non-invasive, and speedy approach for diagnosing probable cases of oral cancer, particularly in areas where access to professional healthcare has become limited.
- May 2023; Thermo Fisher Scientific (Thermo Fisher) signed a collaboration agreement with Pfizer to expand the availability of next-generation sequencing (NGS)-based testing for cancer patients in global markets. This collaboration intends to increase lung and breast cancer patients' access to faster analysis of key genes in over 30 countries across Asia, Latin America, the Middle East, and Africa, where advanced genomic testing is limited or unavailable.
- October 2023; A discovery was made by researchers from the International Institute of Information Technology (IIIT-Hyderabad). They found that pictures captured with a smartphone have the potential to be utilized for the initial evaluation of oral cancer. With the support of Artificial Intelligence, this system has the capability to aid in the timely identification of unusual lesions that might progress into malignancies. This innovative model resulted from a collaborative effort between IIIT-H's iHub-Data and INAI, an applied AI research center supported by Intel, the Telangana Government, the Public Health Foundation of India, and IIIT-H.
Market Opportunities and Challenges
Opportunities- The main reasons contribute to the huge expansion of the oral cancer fast test kit market. One of the key reasons is the rising global incidence of oral cancer. According to the World Health Organization (WHO), oral cancer is one of the most frequent malignancies, especially in developing nations with heavy tobacco and alcohol consumption. This rising prevalence has increased demand for early detection methods, resulting in the emergence of promptly test kits. Another important element is the increased public and healthcare professional awareness of the value of early diagnosis. Early detection of oral cancer results in much better treatment outcomes and survival rates.
Challenges- The market for oral cancer quick test kits is expanding, it faces a number of critical challenges that could hinder its development and operation. One of the most significant obstacles is the general public's lack of awareness and information regarding oral cancer, as well as the availability of fast test kits among healthcare providers. Many regions, particularly in developing countries, continue to lack education and awareness about the early warning symptoms of oral cancer and the necessity of early identification. This awareness gap may result in underutilization of certain diagnostic tools. Another important obstacle is the high expense of sophisticated diagnostic tools.
Market Competitive Landscape
The Oral Cancer Rapid Test Kit Market is a highly competitive arena due to the presence of multiple global and regional companies in the competitive environment. Leading companies in the industry are Abviris Deutschland GmbH, Insilixa, University of Sheffield, Vigilant Biosciences, ThermoFisher, Bio-Rad and Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By End-User, By Principle
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
|
| Companies Covered | Abviris Deutschland GmbH, Insilixa, Vigilant Biosciences, ThermoFisher, Bio-Rad.
|
COVID-19 Impact on Global Oral Cancer Rapid Test Kit Market
The COVID-19 pandemic has had a significant impact on many aspects of the healthcare business, including the oral cancer quick test kit market. One of the most serious consequences of the pandemic has been the disruption of ordinary healthcare services, including as cancer screenings. During the peak of the epidemic, several healthcare facilities postponed or discontinued non-emergency medical services in order to focus resources on addressing COVID-19 victims. This resulted in a considerable reduction in the number of oral cancer tests, lowering demand for quick test kits. The reallocation of healthcare resources to battle the epidemic also entailed funding and including cancer diagnostics.
Key Target Audience:
- Hospitals and Clinics
- Diagnostic Laboratories
- Oncologists and Dental Practitioners
- Public Health Departments
- Cancer Research Institutes
- Pharmaceutical and Biotech Companies
- Medical Device Distributors
- Patient Advocacy Groups
Our in-depth analysis of the Oral Cancer Rapid Test Kit Market includes the following segments:
|
By Product:
|
OncAlert Oral Cancer LAB
Lab on Chip
Insilixa Test
Prevo-Check
|
|
By End-User:
|
Hospitals
Diagnostic Centers
Research Centers
Consumer
|
|
By Principle:
|
Sensor-based
Colorimetry
Immunoassay
Others
|
Key Topics Covered in the Report:
- Global Oral Cancer Rapid Test Kit Market Size (FY’2024-FY’2033)
- Overview of Global Oral Cancer Rapid Test Kit Market
- Segmentation of Global Oral Cancer Rapid Test Kit Market by Product (OncAlert Oral Cancer LAB, Lab on Chip, Insilixa Test, Prevo-Check, Others)
- Segmentation of Global Oral Cancer Rapid Test Kit Market by End-User (Hospitals, Diagnostic Centers, Research Centers, Consumer)
- Segmentation of Global Oral Cancer Rapid Test Kit Market by Principle (Sensor-based, Colorimetry, Immunoassay and Others)
- Statistical Snap of Global Oral Cancer Rapid Test Kit Market
- Expansion Analysis of Global Oral Cancer Rapid Test Kit Market
- Problems and Obstacles in Global Oral Cancer Rapid Test Kit Market
- Competitive Landscape in the Global Oral Cancer Rapid Test Kit Market
- Impact of COVID-19 and Demonetization on Global Oral Cancer Rapid Test Kit Market
- Details on Current Investment in Global Oral Cancer Rapid Test Kit Market
- Competitive Analysis of Global Oral Cancer Rapid Test Kit Market
- Prominent Players in the Global Oral Cancer Rapid Test Kit Market
- SWOT Analysis of Global Oral Cancer Rapid Test Kit Market
- Global Oral Cancer Rapid Test Kit Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Oral Cancer Rapid Test Kit Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Oral Cancer Rapid Test Kit Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Oral Cancer Rapid Test Kit Market
7. Global Oral Cancer Rapid Test Kit Market, By Product (USD Million) 2020-2033
7.1. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By Product, 2020-2026
7.2. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By Product, 2027-2033
7.3. OncAlert Oral Cancer LAB
7.4. Lab on Chip
7.5. Insilixa Test
7.6. Prevo-Check
8. Global Oral Cancer Rapid Test Kit Market, By End-User (USD Million) 2020-2033
8.1. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By End-User, 2020-2026
8.2. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By End-User, 2027-2033
8.3. Hospitals
8.4. Diagnostic Centers
8.5. Research Centers
8.6. Consumer
9. Global Oral Cancer Rapid Test Kit Market, By Principle (USD Million) 2020-2033
9.1. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By Principle, 2020-2026
9.2. Global Oral Cancer Rapid Test Kit Market Size, Share and Forecast, By Principle, 2027-2033
9.3. Sensor-based
9.4. Colorimetry
9.5. Immunoassay
9.6. Others
10. Global Oral Cancer Rapid Test Kit Market Forecast, 2020-2033 (USD Million)
10.1. Global Oral Cancer Rapid Test Kit Market Size and Market Share
11. Global Oral Cancer Rapid Test Kit Market, By Region, 2020-2033 (USD Million)
11.1. Global Oral Cancer Rapid Test Kit Market Size and Market Share By Region (2020-2026)
11.2. Global Oral Cancer Rapid Test Kit Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. ABVIRIS DEUTSCHLAND GMBH
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. INSILIXA
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. VIGILANT BIOSCIENCES
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. THERMOFISHER
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. BIO-RAD
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.5.5. others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
